Atara Biotherapeutics Announces First Quarter 2018 Financial Results and Recent Operational Progress
May 08, 2018 11:05 am UTC| Business
SOUTH SAN FRANCISCO, Calif., May 08, 2018 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune...
May 08, 2018 11:05 am UTC| Business
Worldwide Ocaliva net sales of $35.2 million in the first quarter of 20182018 worldwide Ocaliva net sales currently expected to be between $170 million and $185 millionContinuing to advance leading NASH Phase 3 program:...
System-On-Chip Market to hit US$ 206.79 Billion by 2026: Transparency Market Research
May 08, 2018 11:03 am UTC| Business
ALBANY, New York, May 08, 2018 -- According to a new market report pertaining to the system-on-chip market, published by Transparency Market Research, the global system-on-chip market is expected to reach US$ 206.79 Bn...
JD.com Announces First Quarter 2018 Results
May 08, 2018 11:02 am UTC| Business
BEIJING, May 08, 2018 -- JD.com, Inc. (NASDAQ:JD), China’s leading technology driven e-commerce company and retail infrastructure service provider, today announced its unaudited financial results for the quarter ended...
ObsEva SA to Hold First Quarter 2018 Financial Results and Business Update Call on May 16, 2018
May 08, 2018 11:01 am UTC| Business
Geneva, Switzerland and Boston, MA - May 8, 2018- ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that...
Hunt Mining Signs First Gold Concentrate Agreement With Ocean Partners USA Inc.
May 08, 2018 11:01 am UTC| Business
LIBERTY LAKE, Wash., May 08, 2018 -- Hunt Mining Corp. (the “Corporation” or “Hunt”) (TSX-V:HMX) (OTC:HMXZF) is pleased to announce it has signed an Offtake Agreement (“Agreement”) with Ocean Partners USA, Inc. (“Ocean...
Momenta Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update
May 08, 2018 11:01 am UTC| Business
CAMBRIDGE, Mass., May 08, 2018 -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today reported its financial results for the first quarter ended March 31, 2018 and provided a corporate update. “We made important...